Singapore markets close in 34 minutes

Mountain Valley MD Holdings Inc. (MVMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9750-0.0850 (-8.02%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close1.0600
Open1.0300
BidN/A x N/A
AskN/A x N/A
Day's range0.8730 - 1.0599
52-week range0.0421 - 2.0000
Volume752,223
Avg. volume384,416
Market cap243.393M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Mountain Valley MD Proceeding with FDA 505(b)(2) Pathway Application for Novel Ivectosol™
    CNW Group

    Mountain Valley MD Proceeding with FDA 505(b)(2) Pathway Application for Novel Ivectosol™

    And provides update on its BSL-4 and Dose Sparing Adjuvant TrialsTORONTO, March 3, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it has contracted Camargo Pharmaceutical Services, LLC ("Camargo") to provide regulatory consulting services to support MVMD's pursuit of U.

  • /R E P E A T -- Invitation to media - Élisabeth Brière to announce investment to support clean technology development in Cantons-de-l'Est/
    CNW Group

    /R E P E A T -- Invitation to media - Élisabeth Brière to announce investment to support clean technology development in Cantons-de-l'Est/

    EAST ANGUS, QC, March 2, 2021 /CNW Telbec/ - Canada Economic Development for Quebec Regions (CED)The Government of Canada considers the environment and clean technologies as key elements of the economic recovery.With this in mind, Élisabeth Brière, Parliamentary Secretary to the Minister of Economic Development and Official Languages (Economic Development Agency of Canada for the Regions of Quebec), the Honourable Mélanie Joly, invites media representatives to a press conference regarding assistance from Canada Economic Development for Quebec Regions for Concertaction Estrie (ADDERE).

  • Mountain Valley MD Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Veterinary Medicine to Advisory Board
    CNW Group

    Mountain Valley MD Commencing Husbandry Animal Trials, Appoints Seasoned Doctor of Veterinary Medicine to Advisory Board

    TORONTO, March 1, 2021 /CNW/ - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal trials with a third-party preclinical contract research organization ("CRO") to validate the superiority of the Company's injectable solubilized Ivermectin technology, Ivectosol™ 1%, versus current commercially available forms to treat a broad category of animal parasites.